{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:08:02Z","timestamp":1791176882770,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,10,8]],"date-time":"2008-10-08T00:00:00Z","timestamp":1223424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2008,10,8]],"date-time":"2008-10-08T00:00:00Z","timestamp":1223424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull. Math. Biol."],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s11538-008-9338-x","type":"journal-article","created":{"date-parts":[[2008,10,7]],"date-time":"2008-10-07T22:01:23Z","timestamp":1223416883000},"page":"2126-2176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["A Multi-Type HPV Transmission Model"],"prefix":"10.1007","volume":"70","author":[{"given":"Elamin H.","family":"Elbasha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik J.","family":"Dasbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph P.","family":"Insinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,10,8]]},"reference":[{"issue":"21","key":"9338_CR1","first-page":"1","volume":"23","author":"J.C. Abma","year":"2001","unstructured":"Abma,\u00a0J.C., Sonenstein,\u00a0F.L., 2001. Sexual activity and contraceptive practices among teenagers in the United States, 1988 and 1995. Nat. Center Health Stat. Vital Health Stat. 23(21), 1\u20139.","journal-title":"Nat. Center Health Stat. Vital Health Stat."},{"key":"9338_CR2","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/00019606-199812000-00006","volume":"7","author":"C. Aoyama","year":"1998","unstructured":"Aoyama,\u00a0C., Peters,\u00a0J., Senadheera,\u00a0S., et al., 1998. Uterine cervical dysplasia and cancer: identification of c-myc status by quantitative polymerase chain reaction. Diagn. Mol. Pathol. 7, 324\u201330.","journal-title":"Diagn. Mol. Pathol."},{"key":"9338_CR3","first-page":"65","volume":"21","author":"B. Andersen","year":"1996","unstructured":"Andersen,\u00a0B., 1996. Stress and quality of life following cervical cancer. J.\u00a0Nat. Cancer Inst. 21, 65\u20130.","journal-title":"J.\u00a0Nat. Cancer Inst."},{"key":"9338_CR4","volume-title":"The Clinical Handbook of Human Papillomavirus","author":"R.V. Barnabas","year":"2004","unstructured":"Barnabas,\u00a0R.V., Garnett,\u00a0G.P., 2004. The potential public health impact of vaccines against human papillomavirus. In: Prendiville,\u00a0W., Davies,\u00a0P. (Eds.), The Clinical Handbook of Human Papillomavirus. Parthenon Publishing\/Parthenon Medical Communications, Lancaster."},{"key":"9338_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.0030138","volume":"3","author":"R.V. Barnabas","year":"2006","unstructured":"Barnabas,\u00a0R.V., Laukkanen,\u00a0P., Koskela,\u00a0P., et al., 2006. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. PLOS Med. 3, 1\u20139. http:\/\/www.plosmedicine.org.","journal-title":"PLOS Med."},{"key":"9338_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/sj.bjc.6602728","volume":"93","author":"G. Bigras","year":"2005","unstructured":"Bigras,\u00a0G., de Marval,\u00a0F., 2005. The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women. Br. J. Cancer 93, 575\u201381.","journal-title":"Br. J. Cancer"},{"key":"9338_CR7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479","volume":"31","author":"F.X. Bosch","year":"2003","unstructured":"Bosch,\u00a0F.X., de\u00a0Sanjose,\u00a0S., 2003. Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. J.\u00a0Natl. Cancer Inst. Monogr. 31, 3\u20133.","journal-title":"J.\u00a0Natl. Cancer Inst. Monogr."},{"key":"9338_CR8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/aje\/kwj077","volume":"163","author":"A.N. Burchell","year":"2006","unstructured":"Burchell,\u00a0A.N., Richardson,\u00a0H., Mahmud,\u00a0S.M., Trottier,\u00a0H., Tellier,\u00a0P.P., Hanley,\u00a0J., et al., 2006. Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am. J. Epidemiol. 163, 534\u201343.","journal-title":"Am. J. Epidemiol."},{"key":"9338_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1086\/421916","volume":"190","author":"P.E. Castle","year":"2004","unstructured":"Castle,\u00a0P.E., Schiffman,\u00a0M., Bratti,\u00a0M.C., Hildesheim,\u00a0A., Herrero,\u00a0R., et al., 2004. A population-based study of vaginal human papillomavirus infection in hysterectomized women. J.\u00a0Infect. Dis. 190, 458\u201367.","journal-title":"J.\u00a0Infect. Dis."},{"key":"9338_CR10","unstructured":"Center on the Evaluation of Value and Risk in Health. 2006. The cost-effectiveness analysis registry [Internet]. (Boston), Tufts-New England Medical Center, ICRHPS. Available from: http:\/\/www.tufts-nemc.org\/cearegistry\/ (Accessed March 13, 2006)."},{"key":"9338_CR11","unstructured":"Centers for Disease Control and Prevention. 2004. Prevention of genital human papillomavirus infection. Report to Congress, Washington DC, January."},{"key":"9338_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1363\/3601104","volume":"36","author":"H.W. Chesson","year":"2004","unstructured":"Chesson,\u00a0H.W., Blandford,\u00a0J.M., Gift,\u00a0T.L., et al., 2004. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect. Sex. Reprod. Health 36, 11\u20139.","journal-title":"Perspect. Sex. Reprod. Health"},{"key":"9338_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1136\/bmj.326.7392.733","volume":"326","author":"J. Coste","year":"2003","unstructured":"Coste,\u00a0J., Cochand-Priollet,\u00a0B., De Cremoux,\u00a0P., et al., 2003. Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening. BMJ 326, 733.","journal-title":"BMJ"},{"key":"9338_CR14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1471-0528.2002.01554.x","volume":"109","author":"M.E. Cruickshank","year":"2002","unstructured":"Cruickshank,\u00a0M.E., Sharp,\u00a0L., Chambers,\u00a0G., et al., 2002. Persistent infection with human papillomavirus following the successful treatment of high grade cervical intraepithelial neoplasia. BJOG 109, 579\u201381.","journal-title":"BJOG"},{"key":"9338_CR15","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3109\/00016349409006256","volume":"73","author":"D. De Aloysio","year":"1994","unstructured":"De Aloysio,\u00a0D., Miliffi,\u00a0L., Iannicelli,\u00a0T., et al., 1994. Intramuscular interferon-beta treatment of cervical intraepithelial neoplasia II associated with human papillomavirus infection. Acta Obstet. Gynecol. Scand. 73, 420\u201324.","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"9338_CR16","volume-title":"Screening for Cancer: Theory, Analysis, and Design","author":"D.M. Eddy","year":"1980","unstructured":"Eddy,\u00a0D.M., 1980. Screening for Cancer: Theory, Analysis, and Design. Prentice-Hall, Englewood Cliffs."},{"key":"9338_CR17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.7326\/0003-4819-113-3-214","volume":"113","author":"D. Eddy","year":"1990","unstructured":"Eddy,\u00a0D., 1990. Screening for cervical cancer. Ann. Int. Med. 113, 214\u201326.","journal-title":"Ann. Int. Med."},{"key":"9338_CR18","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1002\/(SICI)1097-0258(19991215)18:23<3263::AID-SIM315>3.0.CO;2-3","volume":"18","author":"W.J. Edmunds","year":"1999","unstructured":"Edmunds,\u00a0W.J., Medley,\u00a0G.F., Nokes,\u00a0D.J., 1999. Evaluating the cost-effectiveness of vaccination programmes: a dynamic approach. Stat. Med. 18, 3263\u2013282.","journal-title":"Stat. Med."},{"key":"9338_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/0272989X02239651","volume":"23","author":"M. Brisson","year":"2003","unstructured":"Brisson,\u00a0M., Edmunds,\u00a0W.J., 2003. Economic evaluation of vaccination programs: the impact of herd immunity. Med. Decis. Mak. 23, 76\u20132.","journal-title":"Med. Decis. Mak."},{"key":"9338_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.mbs.2005.05.004","volume":"197","author":"E.H. Elbasha","year":"2005","unstructured":"Elbasha,\u00a0E.H., Galvani,\u00a0A.P., 2005. Vaccination against multiple types. Math. Biosci. 197, 88\u201317.","journal-title":"Math. Biosci."},{"key":"9338_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3201\/eid1301.060438","volume":"13","author":"E. Elbasha","year":"2007","unstructured":"Elbasha,\u00a0E., Dasbach,\u00a0E., Insinga,\u00a0R., 2007. Model for assessing human papillomavirus vaccination strategies. Emerg. Infect. Dis. 13, 28\u20131.","journal-title":"Emerg. Infect. Dis."},{"key":"9338_CR22","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/modpathol.3880698","volume":"15","author":"M.F. Evans","year":"2002","unstructured":"Evans,\u00a0M.F., Mount,\u00a0S.L., Beatty,\u00a0B.G., et al., 2002. Biotinyl-tyramide-based in situ hybridization signal patterns distinguish human papillomavirus type and grade of cervical intraepithelial neoplasia. Mod. Pathol. 15, 1339\u2013347.","journal-title":"Mod. Pathol."},{"key":"9338_CR23","doi-asserted-by":"crossref","first-page":"520","DOI":"10.7326\/0003-4819-117-6-520","volume":"117","author":"M.C. Fahs","year":"1992","unstructured":"Fahs,\u00a0M.C., Mandelblatt,\u00a0J., Schechter,\u00a0C., Muller,\u00a0C., 1992. Cost effectiveness of cervical cancer screening for the elderly. Ann. Int. Med. 117, 520\u201327.","journal-title":"Ann. Int. Med."},{"key":"9338_CR24","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1471-0528.1997.tb11983.x","volume":"104","author":"G. Flannelly","year":"1997","unstructured":"Flannelly,\u00a0G., Langhan,\u00a0H., Jandial,\u00a0L., Mana,\u00a0E., Campbell,\u00a0M., Kitchener,\u00a0H., 1997. A study of treatment failures following large loop excision of the transformation zone for the treatment of cervical intraepithelial neoplasia. Br. J. Obstet. Gynaecol. 104, 718\u201322.","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"9338_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/0272989X9301300202","volume":"13","author":"D. Fryback","year":"1993","unstructured":"Fryback,\u00a0D., Dasbach,\u00a0E., Klein,\u00a0R., et al., 1993. Initial catalog of health-state quality factors. Med. Dec. Mak. 13, 89\u201302.","journal-title":"Med. Dec. Mak."},{"key":"9338_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1098\/rstb.1993.0143","volume":"342","author":"G.P. Garnett","year":"1993","unstructured":"Garnett,\u00a0G.P., Anderson,\u00a0R.M., 1993a. Factors controlling the spread of HIV in heterosexual communities in developing countries: Patterns of mixing between age and sexual activity classes. Philos. Trans. R. Soc. Lond.\u00a0B 342, 137\u201359.","journal-title":"Philos. Trans. R. Soc. Lond.\u00a0B"},{"key":"9338_CR27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00007435-199307000-00001","volume":"20","author":"G.P. Garnett","year":"1993","unstructured":"Garnett,\u00a0G.P., Anderson,\u00a0R.M., 1993b. Contact tracing and the estimation of sexual mixing patterns: The epidemiology of gonoccal infections. Sex. Transm. Dis. 20, 181\u201391.","journal-title":"Sex. Transm. Dis."},{"key":"9338_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/imammb\/11.3.161","volume":"11","author":"G.P. Garnett","year":"1994","unstructured":"Garnett,\u00a0G.P., Anderson,\u00a0R.M., 1994. Balancing sexual partnerships in age and activity stratified model of HIV transmission in heterosexual populations. IMA J. Math. Appl. Med. Biol. 11, 161\u201392.","journal-title":"IMA J. Math. Appl. Med. Biol."},{"key":"9338_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S1386-6532(00)00129-3","volume":"19","author":"G.P. Garnett","year":"2000","unstructured":"Garnett,\u00a0G.P., Waddell,\u00a0H., 2000. Public health paradoxes and the epidemiological impact of an HPV vaccine. J.\u00a0Clin. Virol. 19, 101\u201311.","journal-title":"J.\u00a0Clin. Virol."},{"key":"9338_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/00007435-199605000-00015","volume":"23","author":"G.P. Garnett","year":"1996","unstructured":"Garnett,\u00a0G.P., Hughes,\u00a0J.P., Anderson,\u00a0R.M., Stoner,\u00a0B.P., Aral,\u00a0S.O., Whittington,\u00a0W.L., Handsfield,\u00a0H.H., Holmes,\u00a0K.K., 1996. The determination of the sexual mixing pattern of patients attending STD and other clinics in Seattle, USA, by contact tracing. Sex. Transm. Dis. 23, 248\u201357.","journal-title":"Sex. Transm. Dis."},{"key":"9338_CR31","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1086\/341782","volume":"186","author":"A.R. Giuliano","year":"2002","unstructured":"Giuliano,\u00a0A.R., Harris,\u00a0R., Sedjo,\u00a0R.L., et al., 2002. Incidence, prevalence, and clearance of type-speci\u2026c human papillomavirus infections: The Young Women\u2019s Health Study. J.\u00a0Infect. Dis. 186, 462\u201369.","journal-title":"J.\u00a0Infect. Dis."},{"key":"9338_CR32","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00005650-199806000-00002","volume":"36","author":"M. Gold","year":"1998","unstructured":"Gold,\u00a0M., Franks,\u00a0P., McCoy,\u00a0K., Fryback,\u00a0D., 1998. Toward consistency in cost-utilities analysis. Med. Care 36, 778\u201392.","journal-title":"Med. Care"},{"key":"9338_CR33","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/ijc.11334","volume":"106","author":"S.J. Goldie","year":"2003","unstructured":"Goldie,\u00a0S.J., Grima,\u00a0D., Kohli,\u00a0M., Wright,\u00a0T.C., Weinstein,\u00a0M.C., Franco,\u00a0E., 2003. A comprehensive natural history model of human papillomavirus (HPV) infection and cervical cancer: Potential impact of and HPV 16\/18 Vaccine. Int. J. Cancer 106, 896\u201304.","journal-title":"Int. J. Cancer"},{"key":"9338_CR34","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/jnci\/djh104","volume":"96","author":"S.J. Goldie","year":"2004","unstructured":"Goldie,\u00a0S.J., Kohli,\u00a0M., Grima,\u00a0D., Weinstein,\u00a0M.C., Wright,\u00a0T.C., Bosch,\u00a0F.X., Franco,\u00a0E., 2004. Projected clinical benefits and cost-effectiveness of a human papllomavirus 16\/18 vaccine. J.\u00a0Nat. Cancer Inst. 96, 604\u201315.","journal-title":"J.\u00a0Nat. Cancer Inst."},{"key":"9338_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#","volume":"71","author":"L. Gustafsson","year":"1997","unstructured":"Gustafsson,\u00a0L., Ponten,\u00a0J., Bergstrom,\u00a0R., Adami,\u00a0H.O., 1997. International incidence rates of invasive cervical cancer before cytological screening. Int. J. Cancer 71, 159\u201365.","journal-title":"Int. J. Cancer"},{"key":"9338_CR36","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1046\/j.1524-4733.2003.65241.x","volume":"6","author":"T. Hammerschmidt","year":"2003","unstructured":"Hammerschmidt,\u00a0T., Goertz,\u00a0A., Wagenpfeil,\u00a0S., et al., 2003. Validation of health economic models: the example of EVITA. Value Health 6, 551\u201359.","journal-title":"Value Health"},{"key":"9338_CR37","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","volume":"364","author":"D. Harper","year":"2004","unstructured":"Harper,\u00a0D., Franco,\u00a0E., Wheeler,\u00a0C., Ferris,\u00a0D., Jenkins,\u00a0D., et al., 2004. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364, 1757\u2013765.","journal-title":"Lancet"},{"key":"9338_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0025-5564(97)00014-X","volume":"145","author":"H. Hethcote","year":"1997","unstructured":"Hethcote,\u00a0H., 1997. An age-structured model of pertussis transmission. Math. Biosci. 145, 89\u201336.","journal-title":"Math. Biosci."},{"key":"9338_CR39","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1006\/bulm.1999.0126","volume":"61","author":"M. Schuette","year":"1999","unstructured":"Schuette,\u00a0M., Hethcote,\u00a0H., 1999. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bull. Math. Biol. 61, 1031\u2013064.","journal-title":"Bull. Math. Biol."},{"key":"9338_CR40","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1093\/jnci\/87.18.1365","volume":"87","author":"G.Y.F. Ho","year":"1995","unstructured":"Ho,\u00a0G.Y.F., Burk,\u00a0R.D., Klein,\u00a0S., et al., 1995. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J.\u00a0Natl. Cancer Inst. 87, 1365\u2013371.","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"9338_CR41","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/ijc.20955","volume":"116","author":"H. Hoyer","year":"2005","unstructured":"Hoyer,\u00a0H., Scheungraber,\u00a0C., Kuehne-Heid,\u00a0R., et al., 2005. Cumulative 5-year diagnoses of CIN2, CIN3 or cervical cancer after concurrent high-risk HPV and cytology testing in a primary screening setting. Int. J. Cancer 116, 136\u201343.","journal-title":"Int. J. Cancer"},{"key":"9338_CR42","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/00001648-200211000-00006","volume":"13","author":"J.P. Hughes","year":"2002","unstructured":"Hughes,\u00a0J.P., Garnett,\u00a0G.P., Koutsky,\u00a0L.A., 2002. The theoretical population level impact of a prophylactic human papilloma virus vaccine. Epidemiology 13, 631\u201339.","journal-title":"Epidemiology"},{"key":"9338_CR43","series-title":"Human Papillomaviruses","volume-title":"IARC Monographs on the Evaluation of Carcinogenic Risks to Humans","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"1995","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1995. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Human Papillomaviruses, vol.\u00a064. International Agency for Research on Cancer, Lyons."},{"key":"9338_CR44","unstructured":"Insinga,\u00a0R.P., 2007. The natural history of low-grade cervical intraepithelial neoplasia. Manuscript in preparation."},{"key":"9338_CR45","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1086\/375074","volume":"36","author":"R.P. Insinga","year":"2003","unstructured":"Insinga,\u00a0R.P., Dasbach,\u00a0E.J., Myers,\u00a0E.R., 2003. The health and economic burden of genital warts in a set of private U.S. Health Plans. Clin. Infect. Dis. 36, 1397\u2013403.","journal-title":"Clin. Infect. Dis."},{"key":"9338_CR46","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1158\/1055-9965.355.13.3","volume":"13","author":"R.P. Insinga","year":"2004","unstructured":"Insinga,\u00a0R.P., Glass,\u00a0A.G., Rush,\u00a0B.B., 2004a. Pap screening in a U.S. health plan. Cancer Epidemiol. Biomark. Prev. 13, 355\u201360.","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"9338_CR47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ajog.2004.01.043","volume":"191","author":"R.P. Insinga","year":"2004","unstructured":"Insinga,\u00a0R.P., Glass,\u00a0A.G., Rush,\u00a0B.B., 2004b. Diagnoses and outcomes in cervical cancer screening: a population-based study. Am. J. Obstet. Gynecol. 191, 105\u201313.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"9338_CR48","unstructured":"Insinga,\u00a0R.P., Dasbach,\u00a0E.J., Elbasha,\u00a0E.H., 2006. Epidemiologic natural history and clinical outcomes of human papillomavirus (HPV) disease: a critical review of the literature in the development of an HPV dynamic transmission model. Manuscript in review."},{"issue":"4","key":"9338_CR49","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1158\/1055-9965.EPI-06-0846","volume":"16","author":"R.P. Insinga","year":"2007","unstructured":"Insinga,\u00a0R.P., Dasbach,\u00a0E.J., Elbasha,\u00a0E.H., Liaw,\u00a0K.-L., Barr,\u00a0E., 2007. Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: An evaluation from multiple analytic perspectives. Cancer Epidemiol. Biomark. Prev. 16(4), 709\u201315.","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"9338_CR50","first-page":"669","volume":"56","author":"C. Isacson","year":"1996","unstructured":"Isacson,\u00a0C., Kessis,\u00a0T.D., Hedrick,\u00a0L., et al., 1996. Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res. 56, 669\u201374.","journal-title":"Cancer Res."},{"key":"9338_CR51","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/1097-0215(20000715)87:2<221::AID-IJC11>3.0.CO;2-2","volume":"87","author":"M.V. Jacobs","year":"2000","unstructured":"Jacobs,\u00a0M.V., Walboomers,\u00a0J.M., Snijders,\u00a0P.J., Voorhorst,\u00a0F.J., Verheijen,\u00a0R.H., Fransen-Daalmeijer,\u00a0N., Meijer,\u00a0C.J., 2000. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int. J. Cancer 87, 221\u201327.","journal-title":"Int. J. Cancer"},{"key":"9338_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00145037","volume":"5","author":"V. Kataja","year":"1989","unstructured":"Kataja,\u00a0V., Syrjanen,\u00a0K., Mantyjarvi,\u00a0R., et al., 1989. Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data. Eur. J. Epidemiol. 5, 1\u2013.","journal-title":"Eur. J. Epidemiol."},{"key":"9338_CR53","first-page":"1","volume":"51","author":"H. Keshavarz","year":"2002","unstructured":"Keshavarz,\u00a0H., Hillis,\u00a0S.D., Kieke,\u00a0B.A., et al., 2002. Hysterectomy surveillance-United States, 1994\u2013999. MMWR CDC Surveill. Summ. 51, 1\u2013.","journal-title":"MMWR CDC Surveill. Summ."},{"key":"9338_CR54","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1001\/jama.287.18.2382","volume":"287","author":"J. Kim","year":"2002","unstructured":"Kim,\u00a0J., Wright,\u00a0T., Goldie,\u00a0S., 2002. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 287, 2382\u2013390.","journal-title":"JAMA"},{"key":"9338_CR55","series-title":"National Vital Statistics Reports","volume-title":"Deaths: Final data for 2002","author":"K.D. Kochanek","year":"2004","unstructured":"Kochanek,\u00a0K.D., Murphy,\u00a0S.L., Anderson,\u00a0R.N., Scott,\u00a0C., 2004. Deaths: Final data for 2002. National Vital Statistics Reports, vol.\u00a053(5). National Center for Health Statistics, Hyattsville."},{"key":"9338_CR56","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1056\/NEJMoa020586","volume":"347","author":"L.A. Koutsky","year":"2002","unstructured":"Koutsky,\u00a0L.A., Ault,\u00a0K.A., Wheeler,\u00a0C.M., Brown,\u00a0D.R., Barr,\u00a0E., et al., 2002. A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med. 347, 1645\u2013651.","journal-title":"N. Engl. J. Med."},{"key":"9338_CR57","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/jama.290.6.781","volume":"290","author":"S.L. Kulasingam","year":"2003","unstructured":"Kulasingam,\u00a0S.L., Myers,\u00a0E.R., 2003. Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA 290, 781\u201389.","journal-title":"JAMA"},{"key":"9338_CR58","unstructured":"Kulasingam,\u00a0S., Harper,\u00a0D., Tosteson,\u00a0A., Myers,\u00a0E., 2002. Impact of quality-of-life assumptions on cost-effectiveness of cervical cancer screening. In 20th International Papillomavirus Conference, Paris, France, October 2002 (abstract 121)."},{"key":"9338_CR59","volume-title":"The Social Organization of Sexuality","author":"E. Lauman","year":"1994","unstructured":"Lauman,\u00a0E., Gagnon,\u00a0J., Michael,\u00a0R., Michaels,\u00a0S., 1994. The Social Organization of Sexuality. University of Chicago Press, Chicago."},{"key":"9338_CR60","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.canlet.2005.02.023","volume":"231","author":"K. Matsumoto","year":"2006","unstructured":"Matsumoto,\u00a0K., Yasugi,\u00a0T., Oki,\u00a0A., et al., 2006. IgG antibodies to HPV16, 52, 58 and 6 L1-capsids and spontaneous regression of cervical intraepithelial neoplasia. Cancer Lett. 231, 309\u201313.","journal-title":"Cancer Lett."},{"key":"9338_CR61","unstructured":"McCrory,\u00a0D., Mather,\u00a0D., Bastain,\u00a0L., Datta,\u00a0S., Hasselblad,\u00a0V., Hickey,\u00a0J., Myers,\u00a0E., Nanda,\u00a0K., February 1999. Evaluation of cervical cytology. Evidence Report\/Technology Assessment No. 5 (Prepared by Duke University under Contract No. 290-97-0014). AHCPR Publication No. 99-E010."},{"key":"9338_CR62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1358\/dof.2006.031.02.967420","volume":"3","author":"J.A. McIntyre","year":"2006","unstructured":"McIntyre,\u00a0J.A., Leeson,\u00a0P.A., 2006. GardasilTM: anti-papillomavirus vaccine. Drugs Future 3, 97\u201300.","journal-title":"Drugs Future"},{"key":"9338_CR63","unstructured":"Medstat. 2001. MarketScan R database, Thomson Medstat. Ann Arbor, MI. Rockville, MD: Agency for Health Care Policy and Research. February 1999. Available: http:\/\/www.ahrq.gov\/clinic\/epcsums\/cervsumm.htm."},{"key":"9338_CR64","volume-title":"Sex in America","author":"R. Michael","year":"1994","unstructured":"Michael,\u00a0R., Gagnon,\u00a0J., Lauman,\u00a0E., Kolata,\u00a0G., 1994. Sex in America. Little, Brown & Co, Inc., New York."},{"key":"9338_CR65","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2105\/AJPH.88.5.749","volume":"88","author":"R. Michael","year":"1998","unstructured":"Michael,\u00a0R., Wadsworth,\u00a0J., Feinleib,\u00a0J., Johnson,\u00a0A., Lauman,\u00a0E., Wellings,\u00a0K., 1998. Private sexual behavior, public opinion, and public health policy related to sexualy transmitted diseases: a US-British comparison. Am. J. Public Health 88, 749\u201354.","journal-title":"Am. J. Public Health"},{"key":"9338_CR66","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0029-7844(98)00006-4","volume":"91","author":"M.F. Mitchell","year":"1998","unstructured":"Mitchell,\u00a0M.F., Schottenfeld,\u00a0D., Tortolero Luna,\u00a0G., Cantor,\u00a0S.B., Richards Kortum,\u00a0R., 1998. Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta analysis. Obstet. Gynecol. 91, 626\u201331.","journal-title":"Obstet. Gynecol."},{"key":"9338_CR67","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/oxfordjournals.aje.a010166","volume":"151","author":"E. Myers","year":"2000","unstructured":"Myers,\u00a0E., McCrory,\u00a0D., Nanda,\u00a0K., Bastian,\u00a0L., Matchar,\u00a0D., 2000. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am. J. Epidemiol. 151, 1158\u2013171.","journal-title":"Am. J. Epidemiol."},{"key":"9338_CR68","unstructured":"Myers,\u00a0E., Green,\u00a0S., Lipkus,\u00a0I., 2004. Pateint preferences for health states related to HPV infection: visual analogue scales vs. time trade-off elicitation. In: Proceedings of the 21st International Papillomavirus Conference, 390.2 2004. Mexico City, Mexico."},{"key":"9338_CR69","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0140-6736(98)12490-X","volume":"354","author":"M.A. Nobbenhuis","year":"1999","unstructured":"Nobbenhuis,\u00a0M.A., Walboomers,\u00a0J.M., Helmerhorst,\u00a0T.J., et al., 1999. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354, 20\u20135.","journal-title":"Lancet"},{"key":"9338_CR70","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"D.M. Parkin","year":"2005","unstructured":"Parkin,\u00a0D.M., Bray,\u00a0F., Ferlay,\u00a0J., Pisani,\u00a0P., 2005. Global cancer statistics. CA Cancer J. Clin. 55, 74\u201308.","journal-title":"CA Cancer J. Clin."},{"key":"9338_CR71","first-page":"1238","volume":"11","author":"B.J. Quade","year":"1998","unstructured":"Quade,\u00a0B.J., Park,\u00a0J.J., Crum,\u00a0C.P., et al., 1998. In vivo cyclin E expression as a marker for early cervical neoplasia. Mod. Pathol. 11, 1238\u2013246.","journal-title":"Mod. Pathol."},{"key":"9338_CR72","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/1471-2334-6-174","volume":"6","author":"A. Rao","year":"2006","unstructured":"Rao,\u00a0A., Chen,\u00a0M., Pham,\u00a0B., Tricco,\u00a0A., Gilca,\u00a0V., et al., 2006. Cohort effects in dynamic models and their impact on vaccination programmes: an example from Hepatitis A. BMC Infect. Dis. 6, 174.","journal-title":"BMC Infect. Dis."},{"key":"9338_CR73","unstructured":"Ries,\u00a0L., Eisner,\u00a0M., Kosary,\u00a0C. et al., 2005. SEER cancer statistics review, 1975\u2013002. Bethesda, MD, National Cancer Institute, http:\/\/seer.cancer.gov\/csr\/1975_2002\/."},{"issue":"2","key":"9338_CR74","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ajog.2004.09.026","volume":"192","author":"M. Saint","year":"2005","unstructured":"Saint,\u00a0M., Gildengorin,\u00a0G., Sawaya,\u00a0G.F., 2005. Current cervical neoplasia screening practices of obstetrician\/gynecologists in the US. Am. J. Obstet. Gynecol. 192(2), 414\u20131.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"9338_CR75","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3201\/eid0901.020168","volume":"9","author":"G.D. Sanders","year":"2003","unstructured":"Sanders,\u00a0G.D., Taira,\u00a0A.V., 2003. Cost Effectiveness of a Potential Vaccine for Human Papillomavirus. Emerg. Infect. Dis. 9, 37\u20138.","journal-title":"Emerg. Infect. Dis."},{"key":"9338_CR76","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/01.AOG.0000139834.84628.61","volume":"104","author":"X. Sastre-Garau","year":"2004","unstructured":"Sastre-Garau,\u00a0X., Cartier,\u00a0I., Jourdan-Da Silva,\u00a0N., et al., 2004. Regression of low-grade cervical intraepithelial neoplasia in patients with HLA-DRB1*13 genotype. Obstet. Gynecol. 104, 751\u201355.","journal-title":"Obstet. Gynecol."},{"key":"9338_CR77","first-page":"503","volume":"163","author":"J. Sellors","year":"2000","unstructured":"Sellors,\u00a0J., Mahony,\u00a0J., Kaczorowski,\u00a0J., Lytwyn,\u00a0A., Bangura,\u00a0H., Lorincz,\u00a0A., et al., 2000. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. CMAJ 163, 503\u201308.","journal-title":"CMAJ"},{"key":"9338_CR78","first-page":"871","volume":"167","author":"J. Sellors","year":"2002","unstructured":"Sellors,\u00a0J., Kaczorowski,\u00a0T., Kaczorowski,\u00a0J., Mahony,\u00a0J., Lytwyn,\u00a0A., Chong,\u00a0S., et al., 2002. Prevalence of infection with carcinogenic human papillomavirus among older women. CMAJ 167, 871\u201372.","journal-title":"CMAJ"},{"key":"9338_CR79","first-page":"213","volume-title":"Committee to Study Priorities for Vaccine Development. Institute of Medicine. Vaccines for the 21st Century: A Tool for Decisionmaking. Appendix 11. Human Papillomavirus,","year":"2000","unstructured":"Stratton,\u00a0K., Durch,\u00a0J., Lawerence,\u00a0R. (Eds.), 2000. Committee to Study Priorities for Vaccine Development. Institute of Medicine. Vaccines for the 21st Century: A Tool for Decisionmaking. Appendix 11. Human Papillomavirus, pp. 213\u201322. National Academy Press, Washington."},{"key":"9338_CR80","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program. 2004. (http:\/\/www.seer.cancer.gov) SEER*Stat Database: Survival\u2014SEER 9 Regs Public-Use, Nov 2004 Sub (1973\u2013002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission."},{"key":"9338_CR81","volume-title":"Statistical Abstracts of the United States: Consumer Price Index","author":"US Bureau of Labor Statistics","year":"2002","unstructured":"US Bureau of Labor Statistics, 2002. Statistical Abstracts of the United States: Consumer Price Index. National Center for Health Statistics, Washington."},{"key":"9338_CR82","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","volume":"6","author":"L.L. Villa","year":"2005","unstructured":"Villa,\u00a0L.L., Costa,\u00a0R.L.R., Petta,\u00a0C.A., Andrade,\u00a0R.P., Ault,\u00a0K.A., et al., 2005. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-conrolled multicentre phase II e\u00a2 cacy trial. Lancet Oncol. 6, 271\u201378.","journal-title":"Lancet Oncol."},{"key":"9338_CR83","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1056\/NEJM199911253412201","volume":"341","author":"K.-L. Wallin","year":"1999","unstructured":"Wallin,\u00a0K.-L., Wiklund,\u00a0F., \u00c5ngstr\u00f6m,\u00a0T., et al., 1999. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N. Engl. J. Med. 341, 1633\u2013638.","journal-title":"N. Engl. J. Med."},{"key":"9338_CR84","first-page":"77","volume-title":"Valuing Health Care: Costs, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies","author":"M. Weinstein","year":"1996","unstructured":"Weinstein,\u00a0M., 1996. From cost-effectiveness ratios to resource allocation: Where to draw the line? In: Sloan,\u00a0F. (Ed.), Valuing Health Care: Costs, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies, pp.\u00a077\u20137. Cambridge University Press, New York."},{"key":"9338_CR85","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1524-4733.2003.00234.x","volume":"6","author":"M.C. Weinstein","year":"2003","unstructured":"Weinstein,\u00a0M.C., O\u2019Brien,\u00a0B., Hornberger,\u00a0J., Jackson,\u00a0J., Johannesson,\u00a0M., McCabe,\u00a0C., Luce,\u00a0B.R., 2003. Principles of good decision analytic modeling. Value Health 6, 9\u20137.","journal-title":"Value Health"},{"issue":"2","key":"9338_CR86","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ygyno.2005.01.010","volume":"97","author":"L. Wenzel","year":"2005","unstructured":"Wenzel,\u00a0L., DeAlba,\u00a0I., Habbal,\u00a0R., Kluhsman,\u00a0B.C., Fairclough,\u00a0D., et al., 2005. Quality of life in long-term cervical cancer survivors. Gynecol. Oncol. 97(2), 310\u201317.","journal-title":"Gynecol. Oncol."},{"key":"9338_CR87","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3109\/00016348109155484","volume":"60","author":"L. Westergaard","year":"1981","unstructured":"Westergaard,\u00a0L., Norgaard,\u00a0M., 1981. Severe cervical dysplasia. Control by biopsies or primary conization? A comparative study. Acta Obstet. Gynecol. Scand. 60, 549\u201354.","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"9338_CR88","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1086\/427557","volume":"191","author":"R.L. Winer","year":"2005","unstructured":"Winer,\u00a0R.L., Kiviat,\u00a0N.B., Hughes,\u00a0J.P., Adam,\u00a0D.E., Lee,\u00a0S.K., et al., 2005. Development and duration of human papillomavirus lesions, after initial infection. J.\u00a0Infect. Dis. 191, 731\u201338.","journal-title":"J.\u00a0Infect. Dis."},{"key":"9338_CR89","volume-title":"The Mathematica Book","author":"S. Wolfram","year":"2005","unstructured":"Wolfram,\u00a0S., 2005. The Mathematica Book, 5th edn. Wolfram Media, Wolfram Research, Inc., Champaign.","edition":"5"}],"container-title":["Bulletin of Mathematical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-008-9338-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11538-008-9338-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-008-9338-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-008-9338-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:39:30Z","timestamp":1744166370000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11538-008-9338-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,8]]},"references-count":89,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["9338"],"URL":"https:\/\/doi.org\/10.1007\/s11538-008-9338-x","relation":{},"ISSN":["0092-8240","1522-9602"],"issn-type":[{"value":"0092-8240","type":"print"},{"value":"1522-9602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,8]]},"assertion":[{"value":"5 September 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}